Annual Non Current Assets
$12.60 M
-$4.35 M-25.68%
December 31, 2023
Summary
- As of February 8, 2025, AVTX annual long term assets is $12.60 million, with the most recent change of -$4.35 million (-25.68%) on December 31, 2023.
- During the last 3 years, AVTX annual non current assets has fallen by -$5.15 million (-29.03%).
- AVTX annual non current assets is now -73.93% below its all-time high of $48.32 million, reached on December 31, 2018.
Performance
AVTX Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Non Current Assets
$12.31 M
-$106.00 K-0.85%
September 30, 2024
Summary
- As of February 8, 2025, AVTX quarterly long term assets is $12.31 million, with the most recent change of -$106.00 thousand (-0.85%) on September 30, 2024.
- Over the past year, AVTX quarterly non current assets has dropped by -$106.00 thousand (-0.85%).
- AVTX quarterly non current assets is now -76.32% below its all-time high of $51.97 million, reached on March 31, 2018.
Performance
AVTX Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Non Current Assets Formula
Non Current Assets = Property, Plant, and Equipment + Intangible Assets + Long-Term Investments + Deferred Tax Assets + Other Non-Current Assets
AVTX Non Current Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -25.7% | -0.8% |
| 3 y3 years | -29.0% | -27.4% |
| 5 y5 years | -73.9% | -72.4% |
AVTX Non Current Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -31.4% | at low | -33.0% | at low |
| 5 y | 5-year | -31.5% | at low | -35.1% | at low |
| alltime | all time | -73.9% | >+9999.0% | -76.3% | >+9999.0% |
Avalo Therapeutics Non Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $12.31 M(-0.9%) |
| Jun 2024 | - | $12.41 M(-0.8%) |
| Mar 2024 | - | $12.52 M(-0.7%) |
| Dec 2023 | $8.39 M(-48.9%) | $12.60 M(-24.2%) |
| Sep 2023 | - | $16.61 M(-0.6%) |
| Jun 2023 | - | $16.72 M(-1.6%) |
| Mar 2023 | - | $16.98 M(+0.2%) |
| Dec 2022 | $16.42 M(-73.5%) | $16.95 M(-0.9%) |
| Sep 2022 | - | $17.10 M(-0.6%) |
| Jun 2022 | - | $17.20 M(-5.7%) |
| Mar 2022 | - | $18.24 M(-0.7%) |
| Dec 2021 | $61.84 M(+137.8%) | $18.37 M(+0.1%) |
| Sep 2021 | - | $18.35 M(+9.7%) |
| Jun 2021 | - | $16.72 M(-3.1%) |
| Mar 2021 | - | $17.25 M(-2.8%) |
| Dec 2020 | $26.00 M(+46.7%) | $17.75 M(-2.2%) |
| Sep 2020 | - | $18.15 M(-4.3%) |
| Jun 2020 | - | $18.96 M(+1.7%) |
| Mar 2020 | - | $18.63 M(+1.4%) |
| Dec 2019 | $17.72 M | $18.39 M(-58.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | $44.60 M(-2.4%) |
| Jun 2019 | - | $45.72 M(-5.0%) |
| Mar 2019 | - | $48.13 M(-0.4%) |
| Dec 2018 | $21.93 M(+105.5%) | $48.32 M(-1.7%) |
| Sep 2018 | - | $49.14 M(-2.3%) |
| Jun 2018 | - | $50.31 M(-3.2%) |
| Mar 2018 | - | $51.97 M(+61.7%) |
| Dec 2017 | $10.67 M(+88.5%) | $32.13 M(>+9900.0%) |
| Sep 2017 | - | $97.00 K(+0.8%) |
| Jun 2017 | - | $96.20 K(-5.7%) |
| Mar 2017 | - | $102.00 K(-3.9%) |
| Dec 2016 | $5.66 M(-73.8%) | $106.10 K(+17.4%) |
| Sep 2016 | - | $90.40 K(+120.5%) |
| Jun 2016 | - | $41.00 K(+9.9%) |
| Mar 2016 | - | $37.30 K(+6.0%) |
| Dec 2015 | $21.62 M(+77.8%) | $35.20 K(-98.3%) |
| Sep 2015 | - | $2.04 M(+59.7%) |
| Jun 2015 | - | $1.28 M(+668.1%) |
| Mar 2015 | - | $166.20 K(+6.6%) |
| Dec 2014 | $12.16 M(+194.0%) | $155.90 K |
| Dec 2013 | $4.14 M | - |
FAQ
- What is Avalo Therapeutics annual long term assets?
- What is the all time high annual non current assets for Avalo Therapeutics?
- What is Avalo Therapeutics annual non current assets year-on-year change?
- What is Avalo Therapeutics quarterly long term assets?
- What is the all time high quarterly non current assets for Avalo Therapeutics?
- What is Avalo Therapeutics quarterly non current assets year-on-year change?
What is Avalo Therapeutics annual long term assets?
The current annual non current assets of AVTX is $12.60 M
What is the all time high annual non current assets for Avalo Therapeutics?
Avalo Therapeutics all-time high annual long term assets is $48.32 M
What is Avalo Therapeutics annual non current assets year-on-year change?
Over the past year, AVTX annual long term assets has changed by -$4.35 M (-25.68%)
What is Avalo Therapeutics quarterly long term assets?
The current quarterly non current assets of AVTX is $12.31 M
What is the all time high quarterly non current assets for Avalo Therapeutics?
Avalo Therapeutics all-time high quarterly long term assets is $51.97 M
What is Avalo Therapeutics quarterly non current assets year-on-year change?
Over the past year, AVTX quarterly long term assets has changed by -$106.00 K (-0.85%)